Ann Tucker
- Feb 19, 2021
- 1 min read

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

TUESDAY, MARCH 2nd / 12:00-1:00pm CT

Overdose deaths associated with illicit stimulants have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.

Join the National Council for Behavioral Health as we examine the latest groundbreaking research in the context of current increases in stimulant use. Register here

Recent Posts

See All

SAMHSA Grant Announcements

Adult Reentry Program (Due 3/06) Expanding SUD Treatment and Capacity in Adult Family Drug Courts (Due 3/06) Medication Assisted-Treatment/Prescription Drug and Opioid Addiction (Due 3/07) Grants for

Bill Introduced to Establish Felony Murder Charges for Fentanyl Dealers

U.S. Senate (2/14) -- Senate Republicans have introduced a bill to charge illicit fentanyl drug dealers with murder. The Felony Murder for Deadly Fentanyl Distribution Act would add the distribution o

Lawmakers Urge Biden to Elevate ONDCP Director to Cabinet-Level

U.S. House (2/01) -- Recently, a bipartisan group of 55 lawmakers wrote a letter to President Joe Biden asking that the Director of the White House Office of National Drug Control Policy (ONDCP) be re

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

Recent Posts

Subscribe to the CLASPP Newsletter

Email:

Phone: